Autolus Therapeutics Plc (AUTL)
1.405
-0.06
(-3.77%)
USD |
NASDAQ |
Jun 09, 11:11
Autolus Therapeutics SG&A Expense (Quarterly) : 39.89M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| DBV Technologies SA | 15.36M |
| Cellectis SA | 5.610M |
| Akari Therapeutics Plc | 2.165M |
| Grifols SA | 328.75M |
| Evaxion AS | 1.527M |